“…The first method uses density gradient solutions such as Ficoll‐Paque Plus (GE Healthcare Life Sciences, Pittsburgh, PA, USA) to separate BM‐MNC fraction from other blood cells; however, volume reduction is not achieved . The second method utilizes an automated system such as the MarrowXpress System (CESCA Therapeutics, Rancho Cordova, CA, USA) to separate MNCs while depleting RBC number and reducing sample volume …”